Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article
Open Access

Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer

Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma and Zhiming Shao
Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0492
Yuwei Li
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuzheng Xu
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caijin Lin
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xi Jin
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ding Ma
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ding Ma
  • For correspondence: [email protected] [email protected]
Zhiming Shao
1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zhiming Shao
  • For correspondence: [email protected] [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 21 no. 5 400-415
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2023.0492
PubMed 
38605478

Published By 
Cancer Biology & Medicine
History 
  • Received December 15, 2023
  • Accepted February 19, 2024
  • Published online May 27, 2024.

Article Versions

  • previous version (April 9, 2024 - 03:35).
  • previous version (April 9, 2024 - 04:12).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2024, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

  1. Yuwei Li1,2,3,*,
  2. Yuzheng Xu1,2,3,*,
  3. Caijin Lin1,2,
  4. Xi Jin1,2,
  5. Ding Ma1,2⇑ and
  6. Zhiming Shao1,2,3⇑
  1. 1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  2. 2Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  3. 3Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  1. Correspondence to: Ding Ma and Zhiming Shao, E-mail: dma09{at}fudan.edu.cn and zhimin_shao{at}yeah.net
View Full Text

Funding

  • National Key Research and Development Project of China

    2020YFA0112304
  • National Natural Science Foundation of China

    81922048
  • National Natural Science Foundation of China

    82072922
  • National Natural Science Foundation of China

    91959207
  • National Natural Science Foundation of China

    92159301
  • Program of Shanghai Academic/Technology Research Leader

    20XD1421100
  • Shanghai Key Laboratory of Breast Cancer

    12DZ2260100
  • Clinical Research Plan of SHDC

    SHDC2020CR4002
  • Clinical Research Plan of SHDC

    SHDC2020CR5005
  • SHDC Municipal Project for Developing Emerging and Frontier Technology in Shanghai Hospitals

    SHDC12021103

This work was supported by grants from the National Key Research and Development Project of China (Grant No. 2020YFA0112304), the National Natural Science Foundation of China (Grant Nos. 81922048, 82072922, 91959207, and 92159301), the Program of Shanghai Academic/Technology Research Leader (Grant No. 20XD1421100), the Shanghai Key Laboratory of Breast Cancer (Grant No. 12DZ2260100), the Clinical Research Plan of SHDC (Grant Nos. SHDC2020CR4002 and SHDC2020CR5005), and the SHDC Municipal Project for Developing Emerging and Frontier Technology in Shanghai Hospitals (Grant No. SHDC12021103).

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 21 (5)
Cancer Biology & Medicine
Vol. 21, Issue 5
15 May 2024
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma, Zhiming Shao
Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: 10.20892/j.issn.2095-3941.2023.0492

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer
Yuwei Li, Yuzheng Xu, Caijin Lin, Xi Jin, Ding Ma, Zhiming Shao
Cancer Biology & Medicine May 2024, 21 (5) 400-415; DOI: 10.20892/j.issn.2095-3941.2023.0492
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supporting Information
    • Conflict of interest statement
    • Author contributions
    • Data availability statement
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
  • Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma
  • Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study
Show more Original Article

Similar Articles

Keywords

  • HR+/HER2− breast cancer
  • mammographic calcifications
  • molecular features
  • precision treatment

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire